A Systemic Problem in Metabolite Identification? - Scorecard - MDSpire

A Systemic Problem in Metabolite Identification?

  • By

  • James Strachan

  • February 12, 2026

  • 8 min

Share

Clinical Scorecard: A Systemic Problem in Metabolite Identification?

At a Glance

CategoryDetail
ConditionMisidentification of metabolites linked to cardiovascular and neurological diseases, highlighting systemic issues.
Key Mechanisms
Target Population
Care Setting

Key Highlights

  • PAGIn and PAGly misidentification affects nearly half of NMR studies in humans, impacting clinical interpretations.
  • The correct assignments of PAG and PAGly have been known for decades, yet errors persist.
  • Errors in metabolite identification can lead to incorrect biological interpretations and misdirected research efforts.
  • Species-specific characteristics lead to unique metabolite profiles in humans and rodents, complicating cross-species studies.
  • The problem extends beyond NMR to mass spectrometry and other metabolomics techniques, necessitating broader awareness.

Guideline-Based Recommendations

Diagnosis

    Management

    • Use independent methods or synthetic standards for quantitative validation, such as LC-MS or targeted assays.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Accurate metabolite identification is crucial for understanding disease mechanisms and guiding treatment strategies.

        Clinical Best Practices

        • Evaluate data for biological arguments before use.
        • Adhere to species-specific metabolite identification rules.
        • Promote rigorous peer review and academic standards in metabolomics.
        • Implement ongoing education and training in metabolite identification for researchers.

        References

        Original Source(s)

        Related Content